Buy/Sell position on FLGT. March 3 Quarter earning report date (evaluate)
Genetics could be the technology of tomorrow. Using genetic sequencing, scientists have been able to make new medications for diseases that work very effectively. They have also been able to use genetics to study how certain diseases impact people. This stock has the potential to rise much more. Target the $130-$150 zone.
Fulgent Genetics #FLGT specialised on genetic tests and now making tons of money on COVID-19 ones. They have also equipped hospitals with IT software for tests data processing. Even with vaccines tests will be required for months ahead therefore #FLGT may have some more space to grow. First target $65, then $80
Credit Suiss said 8/01 it's fair price is 42, not 40. Oppenheimer responded today with rising estimate to 130 from 75. Everybody can see the result on the chart. Company is doing great business in tests. Moderna did similarly with vaccine. If the correction pattern will look more or less the same, 80 could become a solid support now. Shorting that kind of paper...
HOLD Gained 38.42% since buy; Raised stop to 53.95 from break even; Stock appears to be setting up or rolling over into stage 3 ; Break out price 74.83; placed alert at 74.74 to consider adding to position. Sold 1/2 on Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable...
What a day, huh? The markets responded positively to the Inauguration but FLGT fell about 10% (13% but it then recovered some). Seems like it is time for a pause for this stock after a long and healthy rally. TECHNICALS Weekly There is bearish divergence between price and rsi (also on the daily, obviously). We can see that FLGT has been riding the 14/21emas...
Broke out of ascending Triangle & supported on 59.92. Might be looking to break back out of previous ATH
Buy at D stop below x, aim for the top of pattern and beyond
Seems to have reached high resistance zone. Possible retracement as high volume on last doji candle may signify exhaustion. May not go below last lower high. But, better to wait for breakout above 55 to go long.
I think Fulgent Genetics is extremely cheap and institutional investors are just barely starting to take notice. The near term catalysts for massive upside are already in play and not priced into the stock.
+ $FLGT pending Emergency Use for its Home COVID Test kit + COVID hospitalization and death at all time high + COVID expected to continue to surge through Jan-Feb + people reluctant to leave the house especially to hospital/COVID test loc. in fear of COVID + older people may have hard time leaving the house + more frequent tests needed for high risk jobs + short...
The Bull Market is strong, the end of 2020 saw many growth names pull in or consolidate which gives a better reward to risk entry. This video is my watchlist. Most of these names are at or near all time highs or multi year highs. There are 34 total stocks on this list. Many of these have IPO'd in the last few years and still have a growth story ahead of them....
Price about to break the ascending triangle. 3 scenarios: 1. Break imminent 2. More range bound within the triangle and then break 3. Fail My targets for 1 and 2 are 75 (the triangle target) and then 100 (Fibo extension). Trade safe.
2ND TIME ENTERING THIS TRADE ; FIRST ENTRY TOO EARLY. Technology company, genetic testing & next gen sequencing solutions. FLGT Crossing 47.83 ALERT STAGE 2/ 34 WK / 1.9% RES/ 36.6% MA VCP 20W/ 50-11%/ 4T 34% INSTITUTIONS NEXT EARNING FEB '21 CRUSHED EARNINGS 12/29/2020 Held price on overall down day in the Russell 2000... Large volume with near...
Im not too optimistic on this one since what I see is on a daily, but not a 4 hour chart. Let's see how it plays out. I want to see if using the A/D would be as effective in this case on a daily with fewer days as opposed to more days to see the signal.
Ema 50 gave a kick to the ass and changed direction